Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages 1534-1540

  Gupta, Tejpal ^a   Jalali, Rakesh ^a   Goswami, Savita ^a   Nair, Vimoj ^a   Moiyadi, Aliasgar ^a   Epari, Sridhar ^a   Sarin, Rajiv ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cognition; Hyperfractionated radiotherapy; Medulloblastoma; Risk stratification

Indexed keywords

ACUTE TOXICITY; CLINICAL OUTCOME; COGNITION; COGNITIVE FUNCTIONS; HEMATOLOGIC TOXICITY; MEDULLOBLASTOMA; MILD MENTAL RETARDATIONS; OVERALL SURVIVAL; POST TREATMENT; PRE-TREATMENT; RISK STRATIFICATION; SIGNIFICANT IMPACTS; TUMOR BED;

CHEMOTHERAPY; DIAGNOSIS; HANDICAPPED PERSONS; RADIOTHERAPY; TOXICITY; TUMORS;

BRAIN;

ADOLESCENT; ARTICLE; BLOOD TOXICITY; CANCER RELAPSE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; FEMALE; HUMAN; HYPERFRACTIONATED RADIATION THERAPY; INTELLIGENCE QUOTIENT; MALE; MEDULLOBLASTOMA; MENTAL DEFICIENCY; MENTAL PERFORMANCE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIOTHERAPY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84863618287     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.037     Document Type: Article

References (24)

1. W.R. Polkinghorn, and N.J. Tarbell Medulloblastoma: Tumorigenesis, current clinical paradigm, and efforts to improve risk stratification Nat Clin Pract Oncol 4 2007 295 304
2. A.C. Paulino Radiotherapeutic management of medulloblastoma Oncology 11 1997 813 823 discussion 823, 827-818, 831
3. N.G. Gottardo, and A. Gajjar Current therapy for medulloblastoma Curr Treat Options Neurol 8 2006 319 334
4. R.J. Packer, and J.L. Finlay Chemotherapy for childhood medulloblastoma and primitive neuroectodermal tumors Oncologist 1 1996 381 393
5. R.J. Packer, J. Goldwein, and H.S. Nicholson Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study J Clin Oncol 17 1999 2127 2136
6. R.J. Packer, A. Gajjar, and G. Vezina Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma J Clin Oncol 24 2006 4202 4208
7. T.E. Merchant, L.E. Kun, and M.J. Krasin Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma Int J Radiat Oncol Biol Phys 70 2008 782 787
8. A.C. Paulino, A. Mazloom, and B.S. Teh Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma Cancer 117 2011 635 641
9. A. Gajjar, M. Chintagumpala, and D. Ashley Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial Lancet Oncol 7 2006 813 820
10. K.S. Bull, H.A. Spoudeas, and G. Yadegarfar Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: A follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG) J Clin Oncol 25 2007 4239 4245
11. C. Carrie, X. Muracciole, and F. Gomez Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol Int J Radiat Oncol Biol Phys 63 2005 711 716
12. D. Wechsler The Wechsler intelligence scale for children 3rd ed. 1991 The Psychological Corporation San Antonio, TX
13. C. Carrie, J. Grill, and D. Figarella-Branger Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: Long-term results of MSFOP 98 J Clin Oncol 27 2009 1879 1883
14. S.L. Palmer, O. Goloubeva, and W.E. Reddick Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis J Clin Oncol 19 2001 2302 2308
15. M.D. Ris, R. Packer, and J. Goldwein Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group study J Clin Oncol 19 2001 3470 3476
16. S.L. Palmer, A. Gajjar, and W.E. Reddick Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma Neuropsychology 17 2003 548 555
17. R.K. Mulhern, T.E. Merchant, and A. Gajjar Late neurocognitive sequelae in survivors of brain tumours in childhood Lancet Oncol 5 2004 399 408
18. T.E. Merchant, E.N. Kiehna, and C. Li Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma Int J Radiat Oncol Biol Phys 65 2006 210 221
19. M.D. Prados, W.M. Wara, and M.S. Edwards Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Early results of a pilot study Int J Radiat Oncol Biol Phys 28 1994 431 438
20. J.C. Allen, B. Donahue, and R. DaRosso Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors Int J Radiat Oncol Biol Phys 36 1996 1155 1161
21. M.H. Marymont, J. Geohas, and T. Tomita Hyperfractionated craniospinal radiation in medulloblastoma Pediatr Neurosurg 24 1996 178 184
22. M.D. Prados, M.S. Edwards, and S.M. Chang Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Results of a Phase II study Int J Radiat Oncol Biol Phys 43 1999 279 285
23. Bollampally S, Kim, S, Mendenhall, NP. Hyperfractionated craniospinal irradiation may reduce treatment related late effects in patients with medulloblastoma. 46th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Atlanta, Georgia. 2004;60(Suppl 1):S411 [abstr 2130].
24. Kortmann RDR, S. Gustafsson, G A randomized multicentre study of hyperfractionated (HFRT) versus standard radiotherapy (STRT) in children with standard risk medulloblastoma. Radiother Oncol 2010;96:S38.